Back to VANGUARD GROUP INC VANGUARD GROUP INC

LYELLYEL
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in LYELL IMMUNOPHARMA INC

VANGUARD GROUP INC holds 826,430 shares of LYEL (LYELL IMMUNOPHARMA INC), worth $25.4M as of 2025-Q4. The position was increased (+6.1% shares). LYEL represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$25.4M

Current Shares

826,430

Total Value Change

+$11.5M

Total Shares Change

-9.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
826,430
+6.1%
$25.4M0.0%$31.59
30
2025-Q3
Increased
779,004
+76.0%
$12.7M0.0%$14.97
42
2025-Q2
Decreased
442,626
-95.5%
$3.9M0.0%$8.94
0
2025-Q1
Decreased
9.7M
-0.3%
$5.2M0.0%$10.82
0
2024-Q4
Decreased
9.8M
-3.0%
$6.3M0.0%$12.42
0
2024-Q3
New
10.1M
-
$13.9M0.0%$30.20
39

Other major holders of LYEL: HHLR ADVISORS, LTD., BlackRock Finance, Inc., PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used